KAPA vs VMC · $18.8M cap vs P/E 35, rev $7.94B
Kairos Pharma, Ltd. (KAPA) versus Vulcan Materials Company (VMC) — a side-by-side from cached financials, not a winner call.
Kairos Pharma, Ltd. (KAPA) is a biotechnology company listed on US.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
KAPA does not have a complete income-statement cache yet.
Latest reported VMC revenue for 2025-12-31 was $7.94B. Net income was $1.08B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
KAPA currently screens at market cap $18.8M. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Not investment advice. Open the KAPA and VMC stock pages for the full models.
Not investment advice.